Comments on USPSTF Review of Medications to Reduce the Risk for Primary Breast Cancer

Comments on USPSTF Review of Medications to Reduce the Risk for Primary Breast Cancer

Date: May 9, 2013   Key words: breast cancer, chemoprevention, SERMs
The USPSTF recently undertook a review of the topic of chemoprevention of primary breast cancer; that is, the use of pharmaceutical agents (i.e., selective estrogen receptor modulators, SERMs) to lower a high risk woman’s chances for developing the disease.